Collider Bias Is an Insufficient Explanation for the Inverse Obesity Paradox in Prostate Cancer
Year: 2025
Type: article
Abstract: ABSTRACT Background Collider bias is often considered a potential explanation when the association between obesity and disease diagnosis differs from that with disease outcome, as seen in the “obesity paradox.” For prostate cancer (PCa), in particular localized PCa, an “inverse” obesity paradox has been observed, where body mass index (BMI) is negatively associated with diagnosis (hazard ratio [HR] ~0.9 per 5‐kg/m2 increase), but positively associated with PCa‐specific death (HR ~ 1.2). However, collider bias in this context remains unexplored. Methods We simulated binary disease diagnosis and outcome data, including the typically unmeasured/unknown background variable (U) that could introduce collider bias. We calculated U‐unadjusted (biased) and U‐adjusted (true) marginal odds ratios (OR) from a case‐only analysis, and determined the bias percentage using . Similar simulations were performed for classical confounding. Results Across a broad range of plausible parameter values for the PCa context, collider bias did not distort the OR of BMI on PCa death by more than 4%, equivalent to a ± 0.04 distortion in the OR estimate for continuous BMI. In comparison, classical confounding showed a higher potential for distorting BMI and PCa death associations than collider bias. Conclusions Collider bias alone is unlikely to explain the inverse obesity paradox in (localized) PCa, reinforcing some mechanistic evidence that the observed positive relationship between BMI and PCa death is real, and not a statistical artifact. This finding emphasizes the importance of exploring alternative mechanisms beyond collider bias to better understand the underlying factors driving this paradox.
Source: Cancer Medicine
DOI: 10.1002/cam4.70871
Authors: Tanja Stocks, Christel Häggström, Josef Fritz
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $4,700
Funder: Cancerfonden
Awards: G3346320329, G3638178440, G8835023716
OpenAlex ID: W4409444731
